WHO declares an influenza pandemic inevitable
This article was originally published in Scrip
The World Health Organisation moved its influenza pandemic alert phase from five to six last night, the highest level. The development was widely expected, and came as something of an anticlimax, with few signs of the panic that healthcare authorities might have predicted a few months ago.
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
An ultra-fast-acting allergy immunotherapy to induce tolerance to house dust mites is being sought in a collaboration between two Swiss biotechs, Anergis and Virometix.
Emerging Company Profile: Austria’s OncoOne could have an anticancer biologic which targets oxidized macrophage migration inhibitor factor ready for the clinic in around two years.